Silobreaker.com    Log In
   My Page    Help   
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 21, 2009 10:00 AM

Published 11/05/2009 by PharmaBiz


Schering-Plough's narlaprevir demonstrates potent antiviral activity in HCV genotype-1 treatment

Schering-Plough Corporation reported that interim results from an ongoing phase-IIa study of narlaprevir (SCH 900518), its investigational, once-daily protease inhibitor, demonstrated potent antiviral activity in treatment-naive patients with chronic hepatitis C virus (HCV) genotype-1. In the...

Share this 

There are no more reports on this story yet.

Quotes

...30 to November 3. "These interim results, while preliminary, are very encouraging, and showed that narlaprevir has potent antiviral activity in hepatitis C" said John Vierling...
Schering-Plough's narlaprevir demonstrates potent antiviral activity in HCV genotype-1 treatment [PharmaBiz - 11/05/2009]
...of the study. "In this study, once-daily narlaprevir greatly improved viral clearance at week four of treatment in genotype-1 hepatitis C infection compared to the control group. We look forward to further results from this ongoing study." Importantly, patients...
Schering-Plough's narlaprevir demonstrates potent antiviral activity in HCV genotype-1 treatment [PharmaBiz - 11/05/2009]

Related Stories

First Reported 11/12/2009 - Updated 11/12/2009 - 9 Documents (in Health)
United Nations - Click to view 360-page
United Nations
More urgent H1N1 treatment needed for at-risk groups with flu symptoms, UN warns
– Immediate H1N1 antiviral treatment for people in at-risk groups with flu symptoms is vital for saving lives, according to updated United Nations guidelines released today, calling for greater urgency than earlier recommendations.But otherwise-healthy ... [United Nations - 11/12/2009]
First Reported 11/03/2009 - Updated 11/03/2009 - 11 Documents (in Corporate Deals)
Merck completes acquisition of Schering-Plough
US pharmaceutical giant Merck & Co. finalized its acquisition of rival Schering-Plough on Tuesday, a 41-billion-dollar deal creating the number two firm in the sector.The completion follows clearance from regulatory authorities in various countries, allowing ... [France24 - Middle East - 11/03/2009]
First Reported 11/03/2009 - Updated 11/04/2009 - 6 Documents (in Corporate Deals)
Merck and Schering-Plough merge as one
Merck & Co., Inc. (NYSE: MRK) and Schering-Plough Corporation (NYSE: SGP) today announced that they will complete their merger shortly after 4:00PM ET today. The companies will begin combined operations tomorrow, November 4, 2009. As previously announced, ... [News-Medical.Net - 11/04/2009]
First Reported 11/04/2009 - Updated 11/05/2009 - 4 Documents (in Corporate Deals)
Merck & Co Inc - Click to view image in its original context
Merck & Co Inc
Merck's acquisition of Schering-Plough is completed
US pharmaceutical company Merck & Co Inc (NYSE:MRK) confirmed on Tuesday that it has completed its USD41.1bn takeover of smaller rival Schering-Plough Corporation (NYSE:SGP).Schering-Plough shareholders will receive 0.5767 shares of the combined company ... [M2 - 11/05/2009]
First Reported 10/29/2009 - Updated 10/30/2009 - 4 Documents (in Corporate Deals)
Schering Plough Corporation - Click to view 360-page
Schering Plough Corporation
Schering-Plough and Merck Get Merger OK, but Need to Make Divestitures
The Federal Trade Commission cleared the way Thursday for Schering-Plough's $41.1 billion acquisition of Merck & Co., but required both companies to make significant divestures. Under the terms of the FTC's consent order, Merck must sell its interest ... [Law.com - Newswire - 10/30/2009]
First Reported 10/30/2009 - Updated 10/30/2009 - 1 Documents (in Corporate Deals)
Merck’s Buy of Schering-Plough Gets FTC Approval
Merck & Co. and Schering-Plough Corp. said they have won merger approval fromthe Federal Trade Commission and antitrust regulators in Switzerland and Canada. ... [FDA News - 10/30/2009]
In Focus
Network

Blogs

sort by: Date | Relevance
Thoughts on What Used to Be Schering-Plough [Corante - 11/07/2009]
So what are we up to now, Day Three of Greater Merck? The merger with Schering-Plough went through earlier this week, and you won't get any more numbers by searching ...
Thoughts on What Used to Be Schering-Plough [In the Pipeline - 11/06/2009]
So what are we up to now, Day Three of Greater Merck? The merger with Schering-Plough went through earlier this week, and you won't get any more numbers by searching ...
FTC clears Merck's acquisition of Schering-Plough [The Deal.com - 10/30/2009]
The Federal Trade Commission gave final U.S. approval Thursday to the merger of two pharmaceutical giants -- Merck & Co.'s $41.1 billion takeover of Schering-Plough ...
FTC clears Merck's acquisition of Schering-Plough [Dealscape - 10/30/2009]
The Federal Trade Commission gave final U.S. approval Thursday to the merger of two pharmaceutical giants -- Merck & Co.'s $41.1 billion takeover of Schering-Plough ...
Selling It, And Selling It Hard [Corante - 11/10/2009]
There's a long, detailed article up over at Bloomberg on the recent run of huge fines for off-label promotion of drugs. Pfizer, Lilly, Bristol-Meyers Squibb, and ...
1 2 3 4 5

Audio/Video

sort by: Date | Relevance
Influenza Round Table: Antiviral Drugs [CDC Streaming Health - YouTube - 10/30/2009]
Mixing Tamiflu in Sweet Liquid [CDC Streaming Health - YouTube - 11/12/2009]
1

  •  
  •  
  •